« Gouging 101 - KV Pharma Drug Jumps from $20 to $1500 | Main | Benlysta Breaks Through with FDA Approval »

03/10/2011

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b014e5fc6cb8f970c

Listed below are links to weblogs that reference More Gouging Part 2:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

bigredbruce

In the Pipeline (Mar 11th) weighs in with its analysis of this situation a byproduct of FDA putting its stamp of approval on the drug and the granting of orphan status
http://seekingalpha.com/article/257803-kv-pharmaceuticals-gets-away-with-pricing-on-makena

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

April 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada